Reuptake inhibitor prescription drugs do nothing to increase the total number of neurotransmitter molecules in the brain. The work by moving neurotransmitter from one place to another and in the process set up conditions that deplete neurotransmitters in many patients taking them.

  Neuro-R is prescribed along with reuptake inhibitor prescription drugs under the supervision of a physician. One of the indications for Neuro-R is to prevent neurotransmitter depletion by reuptake inhibitor drugs.

  For in-depth information on Neuro-R click on:

  Neuro-RE is intended to be used with Neuro-R. After starting Neuro-R for one week if desired results are not seen Neuro-RE is prescribed to increase monoamine neurotransmitter levels further in order to achieve the desired results of treatment.

  Neuro-DE is a medical food used only under the supervision of a physician.

  Neuro-D is a medical food used in the treatment plan of patients with disease that requires dopamine levels that are higher than typical monoamine neurotransmitter diseases such as Parkinsonism and Restless Leg Syndrome. Neuro-D is intended to be prescribed only under the supervision of a physician.

  Neuro-D is the starting point in elevating dopamine levels in disease driven by a need for such an increase.

  Neuro-M is a medical food which under FDA regulation is to be prescribed only under the supervision of a physician.

 Neuro-T is a medical food intended to be used under the supervision of a physician.

 Neuro-T addresses dopamine fluctuations that can occur with the use of L-dopa beyond the abilities of dietary modification to do so.

  Neuro-T is intended to be used with Neuro-D, Neuro-DE, and Neuro-M.

  Use of tyrosine and/or L-dopa can deplete sulfur amino acids. Neuro-C was developed based on first hand data developed during the treatment of patients.

  Neuro-C is intended to be used during treatment with any of the following, Neuro-R, Neuro-RE, Neuro-D, Neuro-DE, Neuro-T, and Neuro-M.